Annual balance sheet for KALA BIO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 92.1 | 70.5 | 50.9 | 51.2 | 7.56 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 17.5 | 1.1 | 0.236 | — | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 124 | 85.9 | 52.9 | 52.8 | 9.49 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.02 | 0.416 | 2.78 | 2.44 | 0 |
| Other Long Term Assets | |||||
| Total Assets | 139 | 86.8 | 55.9 | 55.5 | 9.49 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 37.4 | 25.7 | 8.35 | 17 | 2.49 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 123 | 67.8 | 48.4 | 43.2 | 2.49 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 16.8 | 19 | 7.5 | 12.3 | 7 |
| Total Liabilities & Shareholders' Equity | 139 | 86.8 | 55.9 | 55.5 | 9.49 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |